Details for 2017791821

Up to date per 04.04.2026

Actions

Title / Product Name

SPARSENTAN POUR SON UTILISATION DANS LE TRAITEMENT DU SYNDROME D'ALPORT

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2017791821

EP Publication Number

3525784

E-Number

1880274

Language

PCT Number

US17056538

Publication Date

21.08.2019 A

28.01.2026 B1

Registration Date

28.01.2026

AT Publication Date

15.02.2026

Application Date

13.10.2017

Registration Number

Priorities

13.10.2016

201662407860 P

16.11.2016

201662423079 P

IPC

A61K 31/422 20060101AFI20250321BHEP

Maximum Duration of Protection

13.10.2037

Owner

Travere Therapeutics, Inc.3611 Valley Centre Drive Suite 300 San Diego CA 92130US

Representative

No representatives present

Inventor

KOMERS, Radko01205 SW Mary Failing Drive Portland, Oregon 97219US

SHIH, Alvin1538 Beacon Street Newton, Massachusetts 02468US

Information about Fees